Which antiviral drug class primarily treats Hepatitis C?

The class of antiviral drugs specifically designed for the treatment of Hepatitis C is Hepatitis C therapies. This category includes direct-acting antivirals (DAAs) that target various stages of the viral life cycle, leading to higher cure rates and fewer side effects compared to previous treatments, such as interferon-based therapies. The use of DAAs has revolutionized the management of Hepatitis C, providing effective options for patients with various genotypes of the virus.

Other antiviral classes do not specifically address the Hepatitis C virus. Anti-HIV drugs are focused on the treatment of HIV/AIDS, influenza drugs target influenza viruses, and herpes simplex antivirals are geared toward herpes infections. Each of these drug classes is tailored to their respective viruses, highlighting the importance of using specific antiviral therapies for effective treatment outcomes.